Shingo Konno

2.9k total citations
82 papers, 858 citations indexed

About

Shingo Konno is a scholar working on Neurology, Infectious Diseases and Surgery. According to data from OpenAlex, Shingo Konno has authored 82 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 16 papers in Infectious Diseases and 12 papers in Surgery. Recurrent topics in Shingo Konno's work include Myasthenia Gravis and Thymoma (29 papers), Peripheral Neuropathies and Disorders (19 papers) and Parkinson's Disease and Spinal Disorders (13 papers). Shingo Konno is often cited by papers focused on Myasthenia Gravis and Thymoma (29 papers), Peripheral Neuropathies and Disorders (19 papers) and Parkinson's Disease and Spinal Disorders (13 papers). Shingo Konno collaborates with scholars based in Japan, United States and Belgium. Shingo Konno's co-authors include M. Nakagawa, Kimiaki Utsugisawa, Yuriko Nagane, Masayuki Masuda, Tomihiro Imai, Hiroyuki Murai, Emiko Tsuda, Yasushi Suzuki, Shigeaki Suzuki and Akiyuki Uzawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Shingo Konno

74 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shingo Konno Japan 17 469 273 140 95 87 82 858
Christiane Caudie France 14 451 1.0× 109 0.4× 46 0.3× 28 0.3× 48 0.6× 49 709
Ana Claúdia Celestino Bezerra Leite Brazil 16 282 0.6× 150 0.5× 123 0.9× 21 0.2× 30 0.3× 36 683
Arun Patel India 15 261 0.6× 50 0.2× 35 0.3× 38 0.4× 182 2.1× 37 1.6k
Shozo Okano Japan 15 34 0.1× 97 0.4× 60 0.4× 86 0.9× 104 1.2× 56 608
Ekaterina Martynova Russia 17 59 0.1× 359 1.3× 81 0.6× 27 0.3× 196 2.3× 53 900
D M Fraser United Kingdom 13 97 0.2× 178 0.7× 13 0.1× 102 1.1× 58 0.7× 31 806
Michael D. Lorenz United States 16 72 0.2× 63 0.2× 41 0.3× 53 0.6× 145 1.7× 37 693
K. Voigt Germany 12 64 0.1× 46 0.2× 27 0.2× 95 1.0× 62 0.7× 64 568
Juntaro Kaneko Japan 11 206 0.4× 104 0.4× 6 0.0× 24 0.3× 104 1.2× 23 623
E. J. Bicknell United States 15 40 0.1× 40 0.1× 45 0.3× 99 1.0× 128 1.5× 40 750

Countries citing papers authored by Shingo Konno

Since Specialization
Citations

This map shows the geographic impact of Shingo Konno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shingo Konno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shingo Konno more than expected).

Fields of papers citing papers by Shingo Konno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shingo Konno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shingo Konno. The network helps show where Shingo Konno may publish in the future.

Co-authorship network of co-authors of Shingo Konno

This figure shows the co-authorship network connecting the top 25 collaborators of Shingo Konno. A scholar is included among the top collaborators of Shingo Konno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shingo Konno. Shingo Konno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konno, Shingo, Akiyuki Uzawa, Makoto Samukawa, et al.. (2025). Impact of 2014 Japanese practice guidelines on treatment patterns in patients with myasthenia gravis: an insurance claims database study. BMJ Open. 15(6). e095496–e095496. 2 indexed citations
2.
Suzuki, Shigeaki, Akiyuki Uzawa, Yuriko Nagane, et al.. (2024). Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan. Neurology Clinical Practice. 14(3). e200276–e200276. 16 indexed citations
3.
Konno, Shingo, et al.. (2024). Long-Term Bone Density Changes and Fracture Risk in Myasthenia Gravis: Implications for FRAX® Tool Application. Healthcare. 12(17). 1793–1793. 2 indexed citations
4.
Konno, Shingo, et al.. (2024). Ten-year fracture risk in Japanese patients with myasthenia gravis: A comprehensive assessment using the fracture risk assessment tool. Journal of the Neurological Sciences. 460. 123017–123017. 2 indexed citations
5.
Uzawa, Akiyuki, Shigeaki Suzuki, Satoshi Kuwabara, et al.. (2023). Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis. Neurotherapeutics. 20(2). 518–523. 5 indexed citations
7.
Konno, Shingo, et al.. (2023). Thiamine deficiency unrelated to alcohol consumption presented with urinary retention and Wernicke's encephalopathy: A case report. SHILAP Revista de lepidopterología. 11(8). e7681–e7681. 2 indexed citations
8.
Konno, Shingo, et al.. (2022). Myasthenia Gravis Complicated by Eosinophilic Granulomatosis with Polyangiitis: A Case Report. SHILAP Revista de lepidopterología. 14(2). 314–319. 1 indexed citations
9.
Yoshimura, Satoshi, Rodolfo Thomé, Shingo Konno, et al.. (2019). IL-9 Controls Central Nervous System Autoimmunity by Suppressing GM-CSF Production. The Journal of Immunology. 204(3). 531–539. 21 indexed citations
10.
Nagane, Yuriko, Hiroyuki Murai, Tomihiro Imai, et al.. (2017). Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 7(2). e013278–e013278. 52 indexed citations
11.
Imai, Tomihiro, Kimiaki Utsugisawa, Hiroyuki Murai, et al.. (2017). Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. Journal of Neurology Neurosurgery & Psychiatry. 89(5). 513–517. 15 indexed citations
12.
Konno, Shingo, Shigeaki Suzuki, Masayuki Masuda, et al.. (2015). Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study. PLoS ONE. 10(5). e0126579–e0126579. 23 indexed citations
13.
Sugimoto, Hideki, Shingo Konno, Hiroshi Nakazora, et al.. (2014). The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level. PLoS ONE. 9(11). e113766–e113766. 3 indexed citations
14.
Konno, Shingo, et al.. (2010). A case of neuralgic amyotrophy with anti GT1a antibody. Rinsho Shinkeigaku. 50(6). 415–417. 3 indexed citations
15.
Iwasaki, Yasuo, Yasumitsu Ichikawa, Osamu Igarashi, et al.. (2004). T-588 Protects Motor Neuron Death Following Axotomy. Neurochemical Research. 29(2). 403–406. 5 indexed citations
16.
Iwasaki, Yasuo, Yasumitsu Ichikawa, Osamu Igarashi, et al.. (2003). Temocapril prevents motor neuron damage and upregulation of cyclooxygenase-II in glutamate-induced neurotoxicity. Neurological Research. 25(3). 301–304. 3 indexed citations
17.
Iwasaki, Yasuo, Yasumitsu Ichikawa, Shingo Konno, et al.. (2003). T-588 Protects Motor Neuron Death Against Glutamate-Induced Neurotoxicity. Neurochemical Research. 28(12). 1829–1832. 3 indexed citations
18.
Konno, Shingo, et al.. (2002). Cystic Germinoma Arising from the Right Temporal Lobe. Acta Neurochirurgica. 144(8). 847–848. 5 indexed citations
19.
Madarame, Hiroo, et al.. (1991). Cuboidal epithelium lining of the parietal layer of Bowman's capsule in Afghan pikas (Ochotona rufescens rufescens). Journal of Comparative Pathology. 104(1). 17–21. 1 indexed citations
20.
Konno, Shingo, Hiroo Madarame, Shogo Ikeda, et al.. (1988). Myopathy and Encephalopathy in Chick Embryos Experimentally Infected with Akabane Virusg. Veterinary Pathology. 25(1). 1–8. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026